Astonea Labs
ASTONEALABSLTD NSE
Astonea Labs
HealthcareNSE: ASTONEALABSLTD BSE: 544409 Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹304 Cr
Volatility
Low Risk
P/E Ratio
67.2
EBITDA
₹13.90 Cr
Return on Equity
7.9%
Debt to Equity
0.74
Book Value
₹54.35
52W High
₹301.3
52W Low
₹118
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
3- Stock is trading at 5.32 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 41.3 days to 74.2 days
Growth Rate
Revenue Growth
51.59% higher than
3Y
Net Income Growth
-16.67% lower than
3Y
Cash Flow Change
-248% lower than
3Y
ROE
-72.81%
ROCE
-59.43%
EBITDA Margin (Avg.)
-40.2%
Quarterly Results
| Particulars | Sep 2024 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 47 | 66 | 81 |
| Expenses | 41 | 61 | 73 |
| Operating Profit | 7 | 5 | 8 |
| OPM % | 14% | 8% | 10% |
| Other Income | 0 | 0 | 0 |
| Interest | 2 | 2 | 2 |
| Depreciation | 2 | 2 | 3 |
| PBT | 3 | 2 | 4 |
| Tax % | 24% | 20% | 20% |
| Net Profit | 2 | 1 | 3 |
| EPS in Rs | 2.76 | 1.35 | 2.95 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 30 | 67 | 80 | 98 | 148 |
| Expenses | 24 | 60 | 68 | 82 | 134 |
| Operating Profit | 6 | 7 | 12 | 15 | 14 |
| OPM % | 19% | 11% | 15% | 16% | 9% |
| Other Income | 0 | 0 | 0 | 0 | 1 |
| Interest | 2 | 2 | 3 | 4 | 3 |
| Depreciation | 4 | 4 | 4 | 5 | 5 |
| PBT | 1 | 1 | 5 | 7 | 6 |
| Tax % | 57% | 39% | 24% | 24% | 20% |
| Net Profit | 0 | 1 | 4 | 5 | 5 |
| EPS in Rs | 0.62 | 1.68 | 5.36 | 6.93 | 4.3 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 8 | 8 | 11 |
| Reserves | 3 | 4 | 4 | 11 | 47 |
| Borrowings | 30 | 36 | 42 | 53 | 43 |
| Other Liabilities | 16 | 20 | 26 | 32 | 46 |
| Total Liabilities | 53 | 64 | 81 | 103 | 146 |
| Fixed Assets | 21 | 21 | 22 | 26 | 31 |
| CWIP | 0 | 0 | 2 | 4 | 8 |
| Investments | 0 | 0 | 0 | 0 | 6 |
| Other Assets | 32 | 44 | 57 | 73 | 101 |
| Total Assets | 53 | 64 | 81 | 103 | 146 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -5 | -1 | 8 | 9 | -14 |
| Investing | -3 | -3 | -8 | -11 | -20 |
| Financing | 8 | 4 | 0 | 2 | 34 |
| Net Cash Flow | 0 | 0 | -1 | 0 | 0 |
| Free Cash Flow | -8 | -4 | 0 | -2 | -28 |
| CFO/OP | -75 | -9 | 71 | 70 | -88 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 235 | 104 | 116 | 142 | 129 |
| Inventory Days | 136 | 121 | 161 | 161 | 125 |
| Days Payable | 273 | 128 | 149 | 144 | 150 |
| Cash Conversion Cycle | 98 | 97 | 128 | 159 | 103 |
| Working Capital Days | 98 | 33 | 28 | 22 | 74 |
| ROCE % | — | 8% | 17% | 17% | 11% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Astonea Labs insights
59 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Astonea Labs confirms it is not a Large Corporate under SEBI debt rules. 29 Apr - Astonea Labs confirms it is not a Large Corporate under SEBI debt rules.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Astonea Labs confirms it is not a Large Corporate under SEBI debt rules. 29 Apr - Astonea Labs confirms it is not a Large Corporate under SEBI debt rules.
3
Intimation Under Regulation 30 Of SEBI LODR (Regulations), 2015- Fire Incident At Manufacturing Facility
27 Apr - Fire at Panchkula plant halted operations for about 90 days; damage under assessment, insured. 27 Apr - Fire at Panchkula plant halted operations for about 90 days; damage under assessment, insured.
4
Intimation Under Regulation 30 Of SEBI LODR (Regulations), 2015- Fire Incident At Manufacturing Facility
11h - Fire at Panchkula plant halted operations for about 90 days; damage under assessment, insured. 11h - Fire at Panchkula plant halted operations for about 90 days; damage under assessment, insured.
5
Statement On Redressal Of Investor Grievances/Complaints For The Quarter Ended 31.03.2026
23 Apr - Investor grievance report for quarter ended 31 March 2026 shows zero complaints. 23 Apr - Investor grievance report for quarter ended 31 March 2026 shows zero complaints.
Frequently Asked Questions about Astonea Labs
What does Astonea Labs Ltd do?
Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies[1]
Where is Astonea Labs Ltd (544409) listed?
Astonea Labs Ltd trades as ASTONEALABSLTD on the NSE and under code 544409 on the BSE.
Which sector does Astonea Labs Ltd belong to?
Astonea Labs Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Astonea Labs Ltd?
Astonea Labs Ltd has a market capitalisation of ₹303.8 Cr, which places it in the Small Cap band.
What is the PE ratio of Astonea Labs Ltd?
Astonea Labs Ltd trades at a PE ratio of 67.20, against a book value of ₹54.35 per share.
What is the 52-week high and low of Astonea Labs Ltd?
Over the last 52 weeks Astonea Labs Ltd has traded between ₹118 and ₹301.3.
What is the Return on Equity (ROE) of Astonea Labs Ltd?
Astonea Labs Ltd reported a return on equity of 7.90%. Its debt-to-equity ratio is 0.74.
Company Information
Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544409.md for Astonea Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.